Proton therapy for thoracic reirradiation of non-small cell lung cancer.

about

Proton therapy for thoracic reirradiation of non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q54968869

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Proton therapy for thoracic reirradiation of non-small cell lung cancer.

@en

Proton therapy for thoracic reirradiation of non-small cell lung cancer.

@nl

type

Item

label

Proton therapy for thoracic reirradiation of non-small cell lung cancer.

@en

Proton therapy for thoracic reirradiation of non-small cell lung cancer.

@nl

prefLabel

Proton therapy for thoracic reirradiation of non-small cell lung cancer.

@en

Proton therapy for thoracic reirradiation of non-small cell lung cancer.

@nl

P1476

Proton therapy for thoracic reirradiation of non-small cell lung cancer.

@en

P2093

Abigail T Berman

http://www.w3.org/2001/XMLSchema#string

Hann-Hsiang Chao

http://www.w3.org/2001/XMLSchema#string

P2860

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Relative biological effectiveness of proton beams in clinical therapy.

Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach.

Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.

Clinical implementation of intensity modulated proton therapy for thoracic malignancies.

Systematic review: charged-particle radiation therapy for cancer.

Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer.

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

P304

153-159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TLCR.2018.03.22

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29876314

http://www.w3.org/2001/XMLSchema#string

P932

5960656

http://www.w3.org/2001/XMLSchema#string